Abeona Therapeutics (ABEO) Enterprise Value (2016 - 2025)
Abeona Therapeutics (ABEO) has 15 years of Enterprise Value data on record, last reported at -$207.5 million in Q3 2025.
- For Q3 2025, Enterprise Value fell 88.53% year-over-year to -$207.5 million; the TTM value through Sep 2025 reached -$207.5 million, down 88.53%, while the annual FY2024 figure was -$97.7 million, 85.91% down from the prior year.
- Enterprise Value reached -$207.5 million in Q3 2025 per ABEO's latest filing, up from -$225.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$18.2 million in Q3 2022 and bottomed at -$225.9 million in Q2 2025.
- Average Enterprise Value over 5 years is -$83.0 million, with a median of -$62.3 million recorded in 2024.
- Peak YoY movement for Enterprise Value: skyrocketed 74.41% in 2022, then plummeted 234.62% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$50.9 million in 2021, then fell by 3.09% to -$52.5 million in 2022, then fell by 0.15% to -$52.6 million in 2023, then crashed by 85.91% to -$97.7 million in 2024, then crashed by 112.3% to -$207.5 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$207.5 million in Q3 2025, -$225.9 million in Q2 2025, and -$152.7 million in Q1 2025.